TBX2 and melanoma: In melanoma, TBX2 was shown to promote proliferation and senescence bypass downstream of the PI3K signalling pathway where it activates the expression of the anti-senescence cell cycle regulator E2F1 and represses PTEN, a negative regulator of the AKT/PI3K pathway [13].